RAVANI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 4.338
AS - Asia 2.345
EU - Europa 1.366
SA - Sud America 304
AF - Africa 35
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.393
Nazione #
US - Stati Uniti d'America 4.254
SG - Singapore 953
CN - Cina 582
IT - Italia 290
UA - Ucraina 244
BR - Brasile 238
VN - Vietnam 229
PL - Polonia 172
DE - Germania 171
HK - Hong Kong 170
GB - Regno Unito 136
TR - Turchia 128
FI - Finlandia 100
FR - Francia 69
JP - Giappone 66
IN - India 62
RU - Federazione Russa 54
BD - Bangladesh 46
MX - Messico 37
CA - Canada 35
SE - Svezia 33
IQ - Iraq 26
AR - Argentina 17
NL - Olanda 17
ZA - Sudafrica 17
BE - Belgio 15
CO - Colombia 14
EC - Ecuador 13
AT - Austria 11
ES - Italia 9
ID - Indonesia 9
PK - Pakistan 9
RO - Romania 7
CL - Cile 6
IE - Irlanda 6
LT - Lituania 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
DK - Danimarca 5
JO - Giordania 5
MY - Malesia 5
PH - Filippine 5
VE - Venezuela 5
KE - Kenya 4
KW - Kuwait 4
PA - Panama 4
AU - Australia 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
EG - Egitto 3
IL - Israele 3
IR - Iran 3
KG - Kirghizistan 3
KR - Corea 3
MA - Marocco 3
PE - Perù 3
PY - Paraguay 3
TH - Thailandia 3
TW - Taiwan 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
DZ - Algeria 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
LV - Lettonia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TJ - Tagikistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BF - Burkina Faso 1
BO - Bolivia 1
BT - Bhutan 1
BZ - Belize 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
NC - Nuova Caledonia 1
NP - Nepal 1
SR - Suriname 1
Totale 8.393
Città #
Singapore 534
Ashburn 468
Woodbridge 366
Houston 303
San Jose 299
Fairfield 292
Jacksonville 283
Santa Clara 236
Chandler 230
Beijing 196
Ann Arbor 174
Warsaw 170
Hong Kong 164
Seattle 108
Wilmington 103
Cambridge 99
Izmir 82
Nanjing 79
Ho Chi Minh City 74
Los Angeles 73
New York 66
Hanoi 65
Dallas 62
Tokyo 62
Ferrara 56
Princeton 56
Boardman 49
Lauterbourg 42
Helsinki 36
Shanghai 35
Munich 33
Dearborn 31
Buffalo 27
São Paulo 27
Orem 26
Mexico City 24
San Diego 23
Shenyang 23
Milan 20
Jiaxing 19
Montreal 18
Moscow 18
Changsha 17
Nanchang 17
Manchester 15
Chennai 14
Brooklyn 13
Brussels 13
Frankfurt am Main 13
Haiphong 13
London 13
Stockholm 13
Boston 12
Council Bluffs 12
Denver 12
Hebei 12
Poplar 12
Chicago 11
Ankara 10
Hefei 10
Johannesburg 10
Naples 10
Rio de Janeiro 10
Rome 10
Turku 10
Atlanta 9
Jinan 9
Mountain View 9
Orange 9
Vienna 9
Auburn Hills 8
Basra 8
Bologna 8
Bremen 8
Columbus 8
Da Nang 8
Indiana 8
Kunming 8
The Dalles 8
Baghdad 7
Bogotá 7
Curitiba 7
Jakarta 7
Redwood City 7
Tianjin 7
Cagliari 6
Charlotte 6
Guangzhou 6
Pune 6
San Francisco 6
Centro 5
Dublin 5
Falkenstein 5
Falls Church 5
Hải Dương 5
Mumbai 5
Ningbo 5
Padova 5
Toronto 5
Zhengzhou 5
Totale 5.672
Nome #
Biodistribution of nanostructured lipid carriers: a tomographic study 335
FOCUS ON NANOSTRUCTURED LIPID CARRIERS AND MONOOLEIN AQUEOUS DISPERSIONS 309
Effect of new Curcumin-containing nanostructured lipid dispersions on human keratinocytes proliferative responses 294
Cannabinoid antagonist in nanostructured lipid carriers (NLCs): design, characterization and in vivo study 292
Analysis of the drug release profiles from formulations based on micro and nano systems 235
Cationic lipid nanosystems as carriers for nucleic acids 234
Nuove strategie per la veicolazione di acidi nucleici: nanosistemi cationici a matrice lipidica 232
Clotrimazole Nanoparticle gel for mucosal administration. 220
Budesonide microparticles for the treatment of Crohn's disease 202
Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study 201
Cationic lipid nanosystems as carriers for nucleic acids 197
Lipid nanocarriers containing a Levodopa prodrug with potential antiparkinsonian activity 195
Gelified reverse micellar dispersions as percutaneous formulations 193
Nanosistemi lipidici per la veicolazione di acidi nucleici 191
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 185
Effect of nanostructured lipid vehicles on percutaneous absorption of curcumin 184
Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies 182
Eudragit® microparticles for the release of budesonide: A comparative study 181
Curcumin containing monoolein aqueous dispersions: a preformulative study 179
Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectors 176
Cationic nanostructured lipid carrier (NLC) and monoolein aqueous dispersions (MAD) as potential carriers for nucleic acids 173
Cationic phosphines for the obtaining of non-viral vectors 169
Eudragit® /Pluronic nanoparticles as mucosal delivery system for peptides and proteins: an in vitro study 163
Development of polymethacrylic/poloxamer microparticles for topical administration of biotech drugs 160
Colloidal dispersions for the delivery of acyclovir: A comparative study 157
Liposomes- and ethosomes-associated distamycins: a comparative study 155
Evaluation of percutaneous absorption of naproxen from different liposomal formulations 150
Waste material of propolis as a film forming agent intended to modify the metronidazole release: preparation and characterization 150
Ethosomes for the delivery of anti-HSV-1 molecules: preparation, characterization and in vitro activity. 146
Ethosomes for the delivery of anti-herpetic molecules 131
Eudragit/Pluronic microparticles for topical administration of peptides and proteins 123
Long-chain cationic derivatives of 1,3,5-triaza-7-phosphaadamantane as a tool to obtain new non-viral vectors 123
Long-chain cationic derivatives of PTA (1,3,5-triaza-7- phosphaadamantane) based SLN as new potential non-viral vectors 121
In vivo evaluation of nanostructured lipid labelled with 99mTc 121
Liposomal formulations for percutaneous absorption of naproxen: a comparative study 115
Semisolid formulations based on MAD or NLC for mucosal administration of Clotrimazole 115
Semisolid formulations based on nanostructured lipid carrier (NLC) for vaginal administration of clotrimazole 114
WO3 Colloids Characterized through SdFFF and FlFFF. 112
Protective immunity against genital herpes in mice obtained by non-ionic surfactant vesiclescontaining a secreted recombinant form of gB protein 111
Niosomes containing HSV immunogens as possible vaccine against genital herpes 109
null 109
Macromolecular carriers to enhance distamycins’ activity 104
Intranasal immunization with non-ionic surfactant vescicles containing a secreted recombinant form of gB protein confers protective immunity against genital herpes in mice 101
New strategies for a vaginal delivery of clotrimazole 100
Preparation and characterization of microparticles containing budesonide 99
Eudragit/Pluronic nanoparticles as mucosal delivery system for peptides and proteins: an in vitro study 99
Preformulative study of monoleinaqueous dispersions as drug delivery system for curcumin 98
Preparation and characterization by differential scanning calorimetry of l-dopa prodrug loaded solid lipid nanoparticles 98
SLN-containing cationic phospnines as potential non-viral vectors 97
Nanoparticulate lipidic dispersions for bromocriptine delivery 97
Niosomi contenenti molecole biotecnologiche ad attivita’ antierpetica somministrati per via nasale 90
null 83
In vitro transport studies across rabbit nasal mucosa of a model compound intended for nose-to-brain delivery in post-traumatic stress disorder 62
null 51
null 45
Totale 8.468
Categoria #
all - tutte 34.724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.724


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 0 32
2021/2022480 31 59 32 6 5 14 28 37 14 50 47 157
2022/2023549 58 26 23 61 93 90 11 55 76 2 31 23
2023/2024241 33 25 2 6 14 40 27 30 5 3 6 50
2024/20251.257 30 19 95 59 176 179 31 57 219 91 178 123
2025/20262.984 271 94 222 374 457 207 398 182 294 322 148 15
Totale 8.468